IPO - Renaissance IPO ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
25.90
-0.10 (-0.38%)
As of 9:30AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close26.00
Open25.90
Bid25.96 x 1000
Ask26.06 x 900
Day's Range25.90 - 25.90
52 Week Range24.81 - 31.67
Volume361
Avg. Volume3,507
Net Assets15.81M
NAV26.35
PE Ratio (TTM)N/A
Yield0.43%
YTD Return-5.94%
Beta (3Y Monthly)1.22
Expense Ratio (net)0.60%
Inception Date2013-10-16
Trade prices are not sourced from all markets
  • MarketWatch17 days ago

    Upwork stock initiated at hold by Jefferies, Stifel

    Jefferies analyst Brent Thill and Stifel analyst Scott Devitt both initiated coverage of freelance-marketplace company Upwork Inc. shares with hold ratings on Monday. The stock is inactive in premarket trading. Thill sees a "long runway ahead" to continued annual growth of about 20%, but he deems that growth "relatively modest" given the company's position as market leader. "Although Upwork has good near-term visibility based on project flow and historical transaction trends, its core revenues do not come from longer-term, renewing subscriptions like [software-as-a-service], which may put a cap on valuation," he wrote. Stifel's Devitt sees room for the company to pick up market share but is also concerned about the stock valuation. "We are favorable on the company's position and would revisit our views ahead of potential revenue growth re-acceleration or margin catalysts, or at more attractive valuation levels, all else equal," he wrote. Devitt expects "relative in-line performance" compared with the S&P 500 over the next year. Upwork went public in early October. Shares are trading about 25% above their $15 initial-public-offering price but trading below their opening price. The Renaissance IPO ETF is off 9.9% so far this year, while the S&P 500 has slipped 0.6%.

  • MarketWatch27 days ago

    Software company Qualtrics files to go public

    Qualtrics International Inc., a Utah-based software company filed for an initial public offering Friday. The company did not yet provide a number of shares it expects to offer or an expected price, but said it plans to raise $200 million, which is likely a placeholder amount. The company applied ti list its Class B common shares on the Nasdaq Global Select Market under the ticker symbol "XM." Morgan Stanley and Goldman Sachs are the lead underwriters. The company said its "new category of software" enables organizations to succeed in the "experience economy." Qualtrics said it lost $3.4 million on revenue of $184.2 million during the six months ending June 30, 2018, compared with a loss of $3.71 million on revenue of $131.4 million in the same period a year ago. The company has filed to go public at a time that the Renaissance IPO ETF has tumbled 13.3% over the past three months, while the Nasdaq Composite has lost 4.6% and the Dow Jones Industrial Average has gained 1.7%.

  • MarketWatch27 days ago

    SolarWinds prices reduced IPO at low end of lowered expected range

    SolarWinds Corp. priced its initial public offering at $15 a share, which was at the low end of the expected range, which was lowered on Thursday to $15 to $16 from $17 to $19. The information technology management software company sold 25 million shares, which was lowered from 42 million shares on Thursday, to raise $375 million, and to value the company at $4.57 billion. Of the shares sold, the company offered 20 million shares and selling shareholders sold 5 million shares. The stock is slated to begin trading Friday on the NYSE under the ticker symbol "SWI." The company is going public at a time that the Renaissance IPO ETF has tumbled 12.0% over the past three months and the S&P 500 has slipped 1.3%.

  • MarketWatchlast month

    StoneCo sets IPO terms, expects to sell up to $1.1 billion worth of stock

    StoneCo set terms for it initial public offering, in which the Brazil-based financial technology expects to sell up to $1.10 billion of stock to the public, and to value the company at about $6.17 billion. The company is offering 47.73 million Class A shares, and the IPO is expected to price between $21 and $23 a share. Of the total, the company is offering 40.91 million shares and selling shareholders are offering 6.82 million shares. StoneCo applied to list its stock on the Nasdaq Global Market under the ticker symbol "STNE." Warren Buffett's Berkshire Hathaway Inc. has expressed interest in buying 13.71 million shares in the IPO. For the six months ended June 30, the company had net income of the equivalent of $23.5 million on revenue of $170.2 million, compared with a loss of $20.3 million on revenue of $88.8 million in the same period a year ago. The company is looking to go public at a time that the Renaissance IPO ETF has lost 10.5% over the past three months and the S&P 500 has slipped 1.7%.

  • MarketWatchlast month

    Equillium's stock opens 2.5% above IPO price

    Shares of Equillium rose in their public debut, as they opened 2.5% above the initial public offering price. The first trade was at $14.35 at 11:12 a.m. Eastern for 130,085 shares. The stock edged higher since to be up 4.3%. The IPO priced late Thursday at $14, at the bottom of the expected range of $14 to $16, to value the biotechnology company at about $233.8 million. Equillium sold 4.67 million shares to raise about $65.4 million. The company went public at a time that the Renaissance IPO ETF has dropped 11.6% over the past three months, the IShares Nasdaq Biotechnology ETF has shed 5.8% and the S&P 500 has slipped 1.1%.

  • MarketWatchlast month

    Anaplan's stock opens 43% above IPO price

    Shares of Anaplan Inc. soared in their public debut, as they opened 43% above the cloud platform company's initial public offering price. The first trade was at $24.25 at 10:59 a.m. Eastern for 2.4 million shares. the stock has traded in a range of $23.60 to $24.70 since. The IPO priced late Thursday at $17, at the top of the expected range of $15 to $17, to value the company at about $2.1 billion. Anaplan sold 15.5 million shares to raise $263.5 million. The company went public at a time that the Renaissance IPO ETF has dropped 11.5% over the past three months and the S&P 500 has slipped 1.1%.

  • MarketWatchlast month

    Livent's stock opens below IPO price, which was below expected range

    Shares of Livent Corp. declined in their public debut, after the lithium producer's initial public offering priced below expectations. The first trade was at $16.25 at 10:05 a.m. ET for 1.99 million share, or 4.4% below the IPO price of $17. The IPO was expected to price at $18 to $20 a share. The company sold 20 million shares to raise $340 million. The shares of declined since the open, and were recently shedding 5.3%. The company has gone public at a time that the Renaissance IPO ETF has lost 10.5% over the past three months while the S&P 500 has gained less than 0.1%.

  • MarketWatchlast month

    OFS Credit's stock opens below IPO price, and extends decline

    Shares of OFS Credit Co. Inc. didn't get a great reception in their public debut, as they opened below their initial public offering price of $20 and fell either further. The first trade was at $19 at 10:51 a.m. ET for 137,500 shares, which was 5% below the IPO price. It hasn't traded above $19 intraday, while hitting a low of $18, since then. The closed-end management investment company sold 2.5 million shares in the IPO to raise $50 million. The company went public at a time that the Renaissance IPO ETF has edged up 1.0% year to date and the S&P 500 has gained 7.7%.

  • MarketWatchlast month

    Elastic stock soars in public debut, at one point doubling the IPO price

    Shares of Elastic N.V. soared in their public debut, at one point trading at double the $36 initial public offering price. The first trade was at $70.00 at 11:36 a.m. ET for 1.25 million shares, or 94% above the IPO price, which was above the expected range of $33 to $35. The stock hit an intraday high of $72 soon after the open, and was last up 98%. The Netherlands-based big data search company raised $252 million in the IPO, with the pricing valuing the company at about $2.5 billion. The stock has gone public at a time that the Renaissance IPO ETF has lost 4.9% over the past three months while the S&P 500 has gained 5.3%.

  • MarketWatchlast month

    Elastic IPO prices above expected range to value company at $2.5 billion

    Elastic N.V. priced its initial public offering of 7 million shares at $36 a share, to raise $252 million, and to value The Netherlands-based big data search company at about $2.50 billion. The pricing late Thursday was above the expected range of $33 to $35 a share. If the underwriters, led by Goldman Sachs and J.P. Morgan Securities, exercise all the options to buy additional shares, the company could raise up to $289.8 million. The stock is expected to begin trading Friday morning on the NYSE under the ticker symbol "ESTC." The company had a net loss of $52.7 million on revenue of $159.9 million in fiscal 2018 ended April 30, compared with a loss of $52.0 million on revenue of $88.2 million a year ago. The company is going public at a time that the Renaissance IPO ETF has gained 2.8% year to date while the S&P 500 has advanced 8.5%.

  • MarketWatchlast month

    Blank check company Collier Creek prices IPO

    New York-based blank check company Collier Creek Holdings said late Thursday that its initial public offering of 40 million shares priced at $10 a share. Each shares includes one Class A ordinary share and one-third of one redeemable warrant to buy on Class A share at a $11.50. The units will be listed on the NYSE under the ticker symbol "CCH.U." Once the shares begin trading separately, the Class A shares will be listed on the NYSE under the ticker symbol "CCH." The company, founded by Chinh Chu, Roger Deromedi and Jason Giordano, was incorporate for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or other similar business combination, with an intention to focus in the consumer goods industry and related sectors. Citigroup, Credit Suisse and BofA Merrill Lynch are acting as joint book-running managers. The company is going public at a time that the Renaissance IPO ETF has lost 3.3% over the past three months and the S&P 500 has gained 6.0%.

  • MarketWatchlast month

    Kodiak Sciences' stock trades little changed in its debut, after the IPO prices well below the expected range

    Shares of Kodiak Sciences Inc. debuted with little fanfare, as they traded little changed after the biotechnology company's initial public offering priced well below the expected range. The first trade was at $10 at 11:30 a.m. ET for 480,541 shares, matching the IPO price of $10, which valued the company at $318.3 million. The IPO was expected to price between $13 and $15. The company sold 9 million shares to raise $90 million. Kodiak has gone public at a time that the Renaissance IPO ETF has gained 3.3% year to date, while the iShares Nasdaq Biotechnology ETF has tacked on 11% and the S&P 500 has advanced 8.6%.

  • MarketWatchlast month

    Guardant Health's stock soars in public debut after IPO prices above expectations

    Shares of Guardant Health Inc. soared in their public debut Thursday, as they opened 46% above the initial public offering price, which was well above the expected range. The first trade for the cancer detection and treatment company's stock was at $27.75 at 10:48 a.m. ET for 1.7 million shares. That compares with the IPO price of $19, which was above the expected range of $15 to $17. The stock has extended gains since then, to trade up 51%. The company raised $237.5 million with the IPO, which values the company at $1.6 billion. Guardant is going public at a time that the Renaissance IPO ETF has slipped 0.9% over the past three months, while the iShares Nasdaq Biotechnology ETF has gained 7.5% and the S&P 500 has advanced 7.1%.

  • MarketWatchlast month

    Kodiak Sciences IPO prices well below expected range

    Kodiak Sciences Inc. said Thursday its initial public offering priced at $10 a share, which is below the expected range of $13 to $15 a share. The Palo Alto, Calif.-based biopharmaceutical company raised $90 million in the IPO. If all the options granted to underwriters are exercised, the company could raise $93.15 million. The pricing values Kodiak at $318.29 million. The stock is expected to begin trading Thursday on the Nasdaq under the ticker symbol "KOD." Morgan Stanley and BofA Merrill Lynch are the lead underwriters. The company had a net loss of $27.9 million and no revenue in 2017, compared with a loss of $17.1 million and no revenue in 2016. The company is going public at a time that the Renaissance IPO ETF has slipped 0.9% over the past three months and the S&P 500 has gained 7.8%.

  • MarketWatchlast month

    Tencent Music Entertainment files IPO paperwork

    Tencent Music Entertainment Group on Tuesday filed paperwork with the Securities and Exchange Commission for an initial public offering. The company has applied to list American depository shares on the NYSE or the Nasdaq under the ticker symbol TME. Tencent Music Entertainment counts Tencent Holdings Ltd. as its controlling shareholder. The company grew revenue by 92% in the first six months of the year relative to a year earlier, to the equivalent of $1.3 billion. Earnings per share climbed 273% over that period, to an equivalent of 8 cents. Tencent Music Entertainment calls itself the largest music entertainment platform in China and says it operates the top four music-oriented apps in the country, based on monthly active users. It runs a music-streaming platform and also provides online karaoke services. The filing comes as the Renaissance IPO ETF is up 5.8% on the year and the S&P 500 has gained 9.6%.

  • MarketWatchlast month

    Anaplan sets terms for IPO to raise up to $232.5 million and be valued at over $1.8 billion

    Anaplan Inc. has set terms for its initial public offering, in which the cloud-based connected planning company could raise up to $232.5 million and be valued at up to $1.83 billion. The San Francisco-based company said the IPO for 15.5 million shares is expected to price between $13 to $15 a share, and trade on the New York Stock Exchange under the ticker symbol "PLAN." All the shares being offered are being sold by the company. Anaplan will grant the underwriters options to buy an additional 2.325 million shares. If all the options are exercised, the company could raise up to $267.4 million. The lead underwriters of the offering are Goldman Sachs, Morgan Stanley and Barclays. The company, with 1,102 employees as of July 31, recorded a loss of $46.7 million on revenue of $168.4 million for the year ended Jan. 31, 2018 compared a loss of $42.7 million on revenue of $120.5 million the year before. The company is looking to go public at a time that the Renaissance IPO ETF has gained 2.0% over the past three months and the S&P 500 has rallied 7.4%.

  • MarketWatch2 months ago

    Slack steps up efforts for IPO as early as first quarter 2019--WSJ report

    Slack Technologies Inc. is actively preparing to go public as soon as the first quarter of 2019, according to a report in The Wall Street Journal. The report, citing people familiar with the company's plans, said the business messaging company expects the initial public offering to lead to a valuation well in excess of about $7 billion, which would make Slack the largest technology IPO since Snap Inc.'s in 2017 valued Snap at about $24 billion. Slack has been working on being ready for an IPO since 2017, but recently stepped up its efforts, the WSJ report said. The report comes at a time that the Renaissance IPO ETF has rallied 7.2% year to date through Thursday, while the S&P 500 has gained 9.0%.

  • MarketWatch2 months ago

    Ra Medical's stock soars to pace NYSE gainers after public debut

    Shares of Ra Medical Systems Inc. rallied 17% in afternoon trade, enough to pace the NYSE's gainers, after their public debut earlier in the session. The first trade was at $21.50 at 10:01 ET, which was 26.5% above the $17 initial public offering price. The pricing was above the expected range of $14 to $16. The company sold 3.9 million shares in the IPO to raise $66.3 million, which was more then its previous plan to offer 3.33 million shares. The company makes and excimer laser-based platform used to treat vascular and dermatological diseases. The company went public at a time that the Renaissance IPO ETF has tacked on 3.3% over the past three months and the S&P 500 has gained 8.1%.

  • MarketWatch2 months ago

    Arvin's stock soars in its public debut, after upsized IPO priced at top of expected range

    Shares of Arvinas Inc. soared in their public debut on the Nasdaq exchange, after the biopharmaceutical company's upsized initial public offering priced at the top of the expected range. The first trade was at $21 at 10:36 a.m. ET for 466,365 shares, or 31% above the $16 IPO price. The stock has pared some gains since to trade up 25%. The company had said earlier this month it planned to offer 6.7 million shares in the IPO, but raised it late-Wednesday to 7.5 million. The IPO pricing was at the top of the expected range of $14 to $16, as the company raised $120 million. The company could raise up to $138 million if the underwriters exercise all of the options granted to purchase additional shares. With 32.16 million shares outstanding after the offering, the IPO price values the company at about $514.5 million. The company has gone public at a time that the Renaissance IPO ETF has gained 3.4% over the past three months and the S&P 500 has tacked on 8.2%.

  • ETFs to Add After SurveyMonkey Blockbuster IPO
    Zacks2 months ago

    ETFs to Add After SurveyMonkey Blockbuster IPO

    The successful market debut of SurveyMonkey could pave its entry into a number of ETFs in the coming days.

  • MarketWatch2 months ago

    SurveyMonkey parent's stock soars in public debut after IPO priced above expected range

    Shares of SurveyMonkey parent SVMK Inc. soared in their public debut, as they opened 56% above the initial public offering price of $12. The first trade for the survey-software maker's stock was at $18.75 at 11:13 a.m. ET for 1.9 million shares. The IPO price of $12 was above the expected range of $9 to $11, and the company said it planned to sell 15 million shares rather than the 13.5 million shares that were expected. The stock has rallied further since the open, and was recently 63% above its IPO price. The company could raise $220 million with the IPO, including a planned sale shares to Salesforce.com Inc.'s venture capital arm. The IPO pricing values SVMK at about $1.5 billion. The company went public at a time that the Renaissance IPO ETF has gained 1% over the past three months while the S&P 500 has advanced 7.3%.

  • Another Tech IPO Soars: ETFs in Focus
    Zacks2 months ago

    Another Tech IPO Soars: ETFs in Focus

    This year has been very successful for tech IPOs and Eventbrite was the latest addition to the same as it rose about 70% on its opening day, drawing attention to IPO ETFs.

  • MarketWatch2 months ago

    Viomi's stock soars in its debut, then pulls back sharply

    Shares of China-based Viomi Technology Co. Ltd. shot up as much as 22% above the initial public offering price of $9 in its public debut, before pulling back sharply. After the initial run up to an intraday high of $10.95, the stock fell to a low of $8.97, or 0.3% below its IPO price, before bouncing slightly to be up 0.7% in afternoon trade. The company raised $102.6 million in the IPO, which valued the company at $811.8 million. Viomi has gone public at a time that the Renaissance IPO ETF has gained 2.2% over the past three months, while the S&P 500 has advanced 7.3%.

  • MarketWatch2 months ago

    China's Viomi to go public after pricing IPO at $9 per ADS

    China-based Viomi Technology Co. Ltd. said its initial public offering of 11.4 million shares priced at $9 per American Depositary Receipts to raise $102.6 million If the underwriter of the offering exercise all of the options to buy an additional 1.71 million ADS, the smart-home products company could raise up to $118 million. The stock is expected to begin trading Tuesday on the Nasdaq Stock Market under the ticker symbol "VIOT." The pricing values the company at $811.8 million. The company is going public at a time that the Renaissance IPO ETF has gained 1.8% over the past three months while the S&P 500 has climbed 7.5%.

  • MarketWatch2 months ago

    Elastic sets IPO terms to raise up to $203 million, to be valued at up to $2 billion

    Elastic N.V. has set terms for its proposed initial public offering, in which it could raise up to $203 million. The Mountain View, Calif.-based search company said it expects the IPO to price between $26 to $29 a share, which would value the company between $1.81 billion and $2.02 billion. If the underwriters exercised all the options granted to buy additional shares, the company could raise up to $233.5 million. Elastic's stock is expected to list on the New York Stock Exchange under the ticker symbol "ESTC." Goldman Sach, J.P. Morgan, Barclays and RBC Capital Markets are the lead underwriters. The company lost $49.35 million on revenue of $159.9 million for the year ended April 30, 2018, compared with a loss of $47.8 million on revenue of $88.2 million a year ago. The company is looking to go public at a time the Renaissance IPO ETF has slipped 0.2% over the past three months and the S&P 500 has gained 6.3%.